CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation

The ectonucleotidases CD38 and CD39 have a critical regulatory effect on tumors and viral infections via the adenosine axis. Natural killer (NK) cells produce cytokines, induce cytotoxic responses against viral infection, and acquire immunoregulatory properties. However, the roles of CD38 and CD39 e...

Full description

Bibliographic Details
Main Authors: Shi Qian, Chunbin Xiong, Meiting Wang, Zining Zhang, Yajing Fu, Qinghai Hu, Haibo Ding, Xiaoxu Han, Hong Shang, Yongjun Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.946871/full
_version_ 1817980340003667968
author Shi Qian
Shi Qian
Shi Qian
Chunbin Xiong
Chunbin Xiong
Meiting Wang
Meiting Wang
Zining Zhang
Zining Zhang
Yajing Fu
Yajing Fu
Qinghai Hu
Qinghai Hu
Haibo Ding
Haibo Ding
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Hong Shang
Hong Shang
Yongjun Jiang
Yongjun Jiang
author_facet Shi Qian
Shi Qian
Shi Qian
Chunbin Xiong
Chunbin Xiong
Meiting Wang
Meiting Wang
Zining Zhang
Zining Zhang
Yajing Fu
Yajing Fu
Qinghai Hu
Qinghai Hu
Haibo Ding
Haibo Ding
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Hong Shang
Hong Shang
Yongjun Jiang
Yongjun Jiang
author_sort Shi Qian
collection DOAJ
description The ectonucleotidases CD38 and CD39 have a critical regulatory effect on tumors and viral infections via the adenosine axis. Natural killer (NK) cells produce cytokines, induce cytotoxic responses against viral infection, and acquire immunoregulatory properties. However, the roles of CD38 and CD39 expressed NK cells in HIV disease require elucidation. Our study showed that the proportions of CD38+CD39+ NK cells in HIV-infected individuals were positively associated with HIV viral loads and negatively associated with the CD4+ T cell count. Furthermore, CD38+CD39+ NK cells expressed additional inhibitory receptors, TIM-3 and LAG-3, and produced more TGF-β. Moreover, autologous NK cells suppressed the proliferation of CD8+ T and CD4+ T cells of HIV-infected individuals, and inhibiting CD38 and CD39 on NK cells restored CD8+ T and CD4+ T cell proliferation in vitro. In conclusion, these data support a critical role for CD38 and CD39 on NK cells in HIV infection and targeting CD38 and CD39 on NK cells may be a potential therapeutic strategy against HIV infection.
first_indexed 2024-04-13T22:52:51Z
format Article
id doaj.art-39494e475a8447e68144acb8afffb3eb
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T22:52:51Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-39494e475a8447e68144acb8afffb3eb2022-12-22T02:26:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.946871946871CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferationShi Qian0Shi Qian1Shi Qian2Chunbin Xiong3Chunbin Xiong4Meiting Wang5Meiting Wang6Zining Zhang7Zining Zhang8Yajing Fu9Yajing Fu10Qinghai Hu11Qinghai Hu12Haibo Ding13Haibo Ding14Xiaoxu Han15Xiaoxu Han16Xiaoxu Han17Hong Shang18Hong Shang19Yongjun Jiang20Yongjun Jiang21National Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaDepartment of Clinical Laboratory, Tianjin Medical University General Hospital, Tianjin, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaUnits of Medical Laboratory, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaNational Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, ChinaKey Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, ChinaThe ectonucleotidases CD38 and CD39 have a critical regulatory effect on tumors and viral infections via the adenosine axis. Natural killer (NK) cells produce cytokines, induce cytotoxic responses against viral infection, and acquire immunoregulatory properties. However, the roles of CD38 and CD39 expressed NK cells in HIV disease require elucidation. Our study showed that the proportions of CD38+CD39+ NK cells in HIV-infected individuals were positively associated with HIV viral loads and negatively associated with the CD4+ T cell count. Furthermore, CD38+CD39+ NK cells expressed additional inhibitory receptors, TIM-3 and LAG-3, and produced more TGF-β. Moreover, autologous NK cells suppressed the proliferation of CD8+ T and CD4+ T cells of HIV-infected individuals, and inhibiting CD38 and CD39 on NK cells restored CD8+ T and CD4+ T cell proliferation in vitro. In conclusion, these data support a critical role for CD38 and CD39 on NK cells in HIV infection and targeting CD38 and CD39 on NK cells may be a potential therapeutic strategy against HIV infection.https://www.frontiersin.org/articles/10.3389/fimmu.2022.946871/fullHIVNK cellsCD38CD39negative regulation
spellingShingle Shi Qian
Shi Qian
Shi Qian
Chunbin Xiong
Chunbin Xiong
Meiting Wang
Meiting Wang
Zining Zhang
Zining Zhang
Yajing Fu
Yajing Fu
Qinghai Hu
Qinghai Hu
Haibo Ding
Haibo Ding
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Hong Shang
Hong Shang
Yongjun Jiang
Yongjun Jiang
CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation
Frontiers in Immunology
HIV
NK cells
CD38
CD39
negative regulation
title CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation
title_full CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation
title_fullStr CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation
title_full_unstemmed CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation
title_short CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation
title_sort cd38 cd39 nk cells associate with hiv disease progression and negatively regulate t cell proliferation
topic HIV
NK cells
CD38
CD39
negative regulation
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.946871/full
work_keys_str_mv AT shiqian cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT shiqian cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT shiqian cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT chunbinxiong cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT chunbinxiong cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT meitingwang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT meitingwang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT ziningzhang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT ziningzhang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT yajingfu cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT yajingfu cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT qinghaihu cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT qinghaihu cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT haiboding cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT haiboding cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT xiaoxuhan cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT xiaoxuhan cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT xiaoxuhan cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT hongshang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT hongshang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT yongjunjiang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation
AT yongjunjiang cd38cd39nkcellsassociatewithhivdiseaseprogressionandnegativelyregulatetcellproliferation